Morgan Stanley Xencor Inc Call Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XNCR
# of Institutions
216Shares Held
71.8MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$284 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$234 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.6MShares$195 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$137 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$101 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.53B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...